Pharmaceutical

BMS and Eurofins invest in Indian pharma hubs Andhra Pradesh and Telangana

Facilities in Andhra Pradesh and Telangana accounted for 23% of all sites in India, confirming the area as a key pharma manufacturing hub.

Jun 23, 2023 - 20:00
BMS and Eurofins invest in Indian pharma hubs Andhra Pradesh and Telangana
Facilities in Andhra Pradesh and Telangana accounted for 23% of all sites in India, confirming the area as a key pharma manufacturing hub.
Read the original article

Tags:

Previous Article

NephroDI Therapeutics and MSRD partner to develop therapy for NDI

Next Article

Compliance standards in medicines are evolving rapidly. How can CDMOs keep up?  

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

With little FDA oversight, melatonin supplements vary widely in actual dosage, study finds

With little FDA oversight, melatonin supplements vary w...

Apr 25, 2023

Nuance’s mysterious pricing, speedier digital health evidence reviews, and new breakthrough devices

Nuance’s mysterious pricing, speedier digital health ev...

Jun 2, 2023

Ipsen’s Iqirvo wins European approval for primary biliary cholangitis

Ipsen’s Iqirvo wins European approval for primary bilia...

Sep 24, 2024